OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 113, Issue 1, Pages 29-35 (January 2006)


View previous. 7 of 37 View next.

Nine-Year Incidence of Age-Related Macular Degeneration in the Barbados Eye Studies

Barbados Eye Studies GroupM. Cristina Leske, MD, MPH1Corresponding Author Informationemail address, Suh-Yuh Wu, MA1, Anselm Hennis, MRCP(UK), PhD24, Barbara Nemesure, PhD1, Ling Yang, MS1, Leslie Hyman, PhD1, Andrew P. Schachat, MD3

Received 18 March 2005; accepted 10 August 2005. published online 11 November 2005.

Objective

To provide 9-year incidence estimates of age-related macular degeneration (AMD) in a population of African descent.

Design

Population-based cohort study.

Participants

Two thousand seven hundred ninety-three participants (81% of eligible) after 9 years’ follow-up.

Main Outcome Measures

Nine-year incidence of AMD-related features, based on fundus photographic gradings and/or clinical examinations.

Results

The overall incidence rate of early AMD was 12.6% (95% confidence interval [CI], 11.0%–14.1%), and that of late AMD was 0.7% (95% CI, 0.4%–1.1%). Both increased with age (P<0.05). For early AMD, incidence ranged from 10.7% at 40 to 49 years of age to 16.8% at ≥70 years. For late AMD, incidence increased from 0.1% to 2.3% in the same age groups. Late AMD was more likely to develop in eyes with pigment changes (risk ratio [RR], 5.8; 95% CI, 2.0–16.8) and retinal pigment epithelial atrophy (RR, 5.4; 95% CI, 1.9–15.8) at baseline. Crude RRs indicated significant associations of late AMD to elevated systolic blood pressure and diabetes history, but only the diabetes relationship was suggested after adjusting for age, with borderline statistical significance (age-adjusted RR, 2.7; P = 0.054).

Conclusions

Nine-year data on natural history indicate that early AMD is common in this population of African origin, although late AMD is infrequent. These long-term observations provide further evidence for the lower AMD risk in black populations compared with white populations.

1 Department of Preventive Medicine, Stony Brook University, Stony Brook, New York.

2 Ministry of Health, Bridgetown, Barbados.

3 Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

4 Chronic Disease Research Center, School of Clinical Medicine and Research, University of the West Indies, Barbados.

Corresponding Author InformationCorrespondence and reprint requests to M. Cristina Leske, MD, MPH, Department of Preventive Medicine, Stony Brook University, HSC L3 086, Stony Brook, NY 11794-8036.

 Manuscript no. 2005-242.

Supported by the National Eye Institute, Bethesda, Maryland (grant nos.: EY07625, EY07617).

The authors have no conflicts of interest with regard to the article.

 See “Appendix” for group membership.

PII: S0161-6420(05)01030-4

doi:10.1016/j.ophtha.2005.08.012


View previous. 7 of 37 View next.